GIA
CVS icon

Gladstone Institutional Advisory’s CVS Health CVS Stock Holding History

Gladstone Institutional Advisory’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$864K Buy
8,347
+2,216
+36% +$198K 0.03% 448
2026
Q1 		$440K Sell
6,131
-11,294
-65% -$870K 0.02% 566
2025
Q4 		$1.38M Sell
17,425
-2,330
-12% -$184K 0.05% 310
2025
Q3 		$1.49M Sell
19,755
-5,733
-22% -$393K 0.06% 293
2025
Q2 		$1.76M Buy
25,488
+14,106
+124% +$925K 0.07% 257
2025
Q1 		$771K Sell
11,382
-1,443
-11% -$86.4K 0.04% 378
2024
Q4 		$576K Sell
12,825
-1,731
-12% -$97.1K 0.03% 442
2024
Q3 		$915K Buy
14,556
+2,832
+24% +$165K 0.04% 335
2024
Q2 		$692K Sell
11,724
-44
-0.4% -$2.75K 0.04% 367
2024
Q1 		$939K Sell
11,768
-1,477
-11% -$113K 0.05% 294
2023
Q4 		$1.05M Sell
13,245
-661
-5% -$47K 0.06% 280
2023
Q3 		$971K Buy
13,906
+1,348
+11% +$95.5K 0.06% 270
2023
Q2 		$868K Buy
12,558
+3,056
+32% +$217K 0.05% 301
2023
Q1 		$706K Buy
9,502
+293
+3% +$24.6K 0.05% 346
2022
Q4 		$858K Buy
9,209
+238
+3% +$23K 0.06% 303
2022
Q3 		$856K Sell
8,971
-8,250
-48% -$817K 0.07% 297
2022
Q2 		$1.6M Sell
17,221
-7,421
-30% -$724K 0.13% 186
2022
Q1 		$2.49M Buy
24,642
+387
+2% +$40.7K 0.17% 159
2021
Q4 		$2.5M Buy
24,255
+18,502
+322% +$1.71M 0.19% 144
2021
Q3 		$488K Sell
5,753
-3,342
-37% -$280K 0.05% 330
2021
Q2 		$759K Buy
9,095
+4,089
+82% +$335K 0.09% 229
2021
Q1 		$377K Buy
+5,006
New +$365K 0.06% 282

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Gladstone Institutional Advisory's CVS Position: Q2 2026 in Review

Gladstone Institutional Advisory increased its CVS Health (CVS) stake by 36% in Q2 2026, buying an estimated $198K and bringing the position to 8,347 shares worth $864K. The position accounts for 0.03% of the portfolio, ranked #448.

Gladstone Institutional Advisory first reported a position in CVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.5M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Gladstone Institutional Advisory held 8,347 shares of CVS Health worth $864K as of Q2 2026.
  • Gladstone Institutional Advisory bought 2,216 CVS Health shares in Q2 2026, an estimated $198K.
  • CVS Health made up 0.03% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #448 holding.
  • Gladstone Institutional Advisory first reported a position in CVS Health in Q1 2021 and has held it in 22 quarters since.
  • Gladstone Institutional Advisory's CVS Health position peaked at $2.5M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.